Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The delayed gastric emptying caused by GLP-1 agonists might theoretically contribute to reduced alcohol consumption by altering absorption kinetics and the subjective experience of intoxication, though this hypothesis requires human pharmacokinetic studies for validation
Twenty-five units on a 0.3 mL syringe is 0.25 mL
In a head-to-head trial against semaglutide (the SURPASS-2 trial), tirzepatide produced significantly greater weight loss, with participants taking the highest dose of tirzepatide losing an average of 11.2 kg (24.7 lbs), compared to 5.7 kg (12.5 lbs) for those taking semaglutide 1 mg
Afzal MZ, Dragnev K, Sarwar T, et al
US$ 28.94
US$ 20.78
US$ 24.49
US$ 27.39
